Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Clinical outcomes in a subpopulation of adults with Morquio A syndrome: results from a long-term extension study of elosulfase alfa

Fig. 1

LS mean change from baseline for endurance and uKS level. LS mean change from baseline to week 120 (MOR-005) or year 2 (MorCAP) in (a) 6MWT, (b) 3MSCT, and (c) uKS level. Error bars represent standard error. P values were calculated based on comparison of LS mean assessments at week 120 or year 2 vs baseline. 3MSCT, 3-min stair climb test; 6MWT, 6-min walk test; ITT, intent to treat; LS, least squares; MPP, modified per-protocol; uKS, urinary keratan sulfate

Back to article page